000 | 01901 a2200553 4500 | ||
---|---|---|---|
005 | 20250514024127.0 | ||
264 | 0 | _c20020308 | |
008 | 200203s 0 0 eng d | ||
022 | _a0344-5704 | ||
024 | 7 |
_a10.1007/s00280-001-0380-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEgorin, Merrill J | |
245 | 0 | 0 |
_aPharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats. _h[electronic resource] |
260 |
_bCancer chemotherapy and pharmacology _cJan 2002 |
||
300 |
_a7-19 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xmetabolism |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aBehavior, Animal |
650 | 0 | 4 | _aBenzoquinones |
650 | 0 | 4 |
_aBile _xmetabolism |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 |
_aEating _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aLactams, Macrocyclic |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xpharmacokinetics |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aQuinones _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred F344 |
650 | 0 | 4 | _aTissue Distribution |
700 | 1 | _aLagattuta, Theodore F | |
700 | 1 | _aHamburger, Deborah R | |
700 | 1 | _aCovey, Joseph M | |
700 | 1 | _aWhite, Kevin D | |
700 | 1 | _aMusser, Steven M | |
700 | 1 | _aEiseman, Julie L | |
773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 49 _gno. 1 _gp. 7-19 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-001-0380-8 _zAvailable from publisher's website |
999 |
_c11764001 _d11764001 |